0106 - ANATOMICAL VARIATIONS IN THE DISTAL FEMUR? A CT DATA ANALYSIS OF 24,042 KNEES

The Knee ◽  
2017 ◽  
Vol 24 (6) ◽  
pp. XIII-XIV
Author(s):  
J. Beckmann ◽  
A.F. Steinert ◽  
W.B. Kurtz
2019 ◽  
Vol 477 (3) ◽  
pp. 561-570 ◽  
Author(s):  
Malin Meier ◽  
Sumesh Zingde ◽  
André Steinert ◽  
William Kurtz ◽  
Franz Koeck ◽  
...  

2018 ◽  
Vol 6 (4_suppl2) ◽  
pp. 2325967118S0003
Author(s):  
Cornelia Merz ◽  
Andre Steinert ◽  
Wiliam Kurtz ◽  
Franz Xaver Köck ◽  
Johannes Beckmann

Based on a large quantity of CT data, variations in distal femoral geometry was examined and evaluated for TKA. A retrospective study was performed on 24,042 data sets generated during the process of designing individual knee implants. Following parameters were recorded for the distal femur: Femoral absolute anterior-posterior (AP) and medial-lateral (ML) extent, lateral and medial condyle and trochlea size, distal condylar offset (DCO) between lateral and medial condyle, and the difference between medial and lateral posterior condylar offset (PCO) measured in AP direction. Variable patient geometry was found with analysis of the AP and ML extent. Approximately one-third of the patients would experience size conflicts of +/- 3 mm with standard arthroplasty systems. 62% of the knees had a DCO> 1 mm. 83% of the distal femur had a mediolateral difference in PCO> 2 mm, which corresponds to about 3° external rotation and does not correlate with the femoral size. There is a distinct variability of femoral AP and ML extent as well as offsets / asymmetries. Medial and lateral PCOs are different and do not correlate with femoral size. This first results in mismatches between size of implant and individual knee anatomy and secondly in possible softtissue release and different femoral external rotations to adapt systems with fixed distal geometry to the individual situation.


2016 ◽  
Author(s):  
Daniel Fitzsimons ◽  
Gunnar Oeltzschner ◽  
Christopher Ovens ◽  
Dirk Radies ◽  
Frauke Schulze

2019 ◽  
Vol 28 (4) ◽  
pp. 1105-1112 ◽  
Author(s):  
Malin Meier ◽  
Sumesh Zingde ◽  
Raymond Best ◽  
Lennart Schroeder ◽  
Johannes Beckmann ◽  
...  

2007 ◽  
Vol 36 (1) ◽  
pp. 45-53 ◽  
Author(s):  
M.C. Metzger ◽  
R. Schön ◽  
R. Tetzlaf ◽  
N. Weyer ◽  
A. Rafii ◽  
...  
Keyword(s):  

Stroke ◽  
2001 ◽  
Vol 32 (suppl_1) ◽  
pp. 375-375
Author(s):  
Randall P Brewer ◽  
Augusto Parra ◽  
Michael B Hopkins ◽  
Cecil O Borel ◽  
James R Reynolds

P197 Background: Magnesium sulfate (MgSO4) has attracted interest as a neuroprotective agent during cerebral ischemia. Passage of Mg ion into the CNS has been poorly examined. The present study assessed the passage of ionized (physiologically-active)Mg into the cerebrospinal fluid (CSF) of patients with intracranial hypertension after MgSO4 infusion. Design: After IRB approval, patients requiring CSF drainage received IV MgSO 4 (5g)in 125 cc NS over 30 min. Plasma and CSF samples were taken hourly for 4 hrs. Intraventricular catheter placement was confirmed by CT. Data analysis involved ANOVA followed by Dunnet’s post hoc test for a significant F statistic (p < 0.05). Results: Nine patients (5/4, male/female; mean age=52) with closed head injury (n=3), subarachnoid hemorrhage (n=2), intracerebral hemorrhage (n=2), hydrocephalus (n=1), and subdural hematoma (n=1) were studied. Mean (±SD)Mg values are presented (table). Baseline Mg was higher in CSF. Although plasma Mg increased, CSF Mg was unchanged. Conclusions: Although the CSF to plasma Mg gradient is maintained in patients with intracranial hypertension, intravenous infusion of 5g MgSO4 does not further increase CSF Mg. This suggests systemic infusion of MgSO4 may not be an effective route of administration for neuroprotection.


2005 ◽  
Vol 1281 ◽  
pp. 783-787
Author(s):  
V. Dicken ◽  
J.-M. Kuhnigk ◽  
L. Bornemann ◽  
S. Zidowitz ◽  
S. Krass ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document